Remote Opioid Monitoring Act of 2025

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2404 Introduced in House (IH)]

<DOC>






119th CONGRESS
  1st Session
                                H. R. 2404

     To provide for a study on the effects of remote monitoring on 
                individuals who are prescribed opioids.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 27, 2025

 Mr. Balderson (for himself and Ms. Kelly of Illinois) introduced the 
   following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
     To provide for a study on the effects of remote monitoring on 
                individuals who are prescribed opioids.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Remote Opioid Monitoring Act of 
2025''.

SEC. 2. PROVIDING FOR A STUDY ON THE EFFECTS OF REMOTE MONITORING ON 
              INDIVIDUALS WHO ARE PRESCRIBED OPIOIDS.

    (a) In General.--Not later than 18 months after the date of 
enactment of this Act, the Comptroller General of the United States 
shall conduct a study and submit to the Committee on Energy and 
Commerce of the House of Representatives and the Committee on Health, 
Education, Labor, and Pensions and the Committee on Finance of the 
Senate a report on the use of remote monitoring with respect to 
individuals who are prescribed opioids.
    (b) Report.--The report described in subsection (a) shall include--
            (1) an assessment of scientific evidence related to the 
        efficacy, individual outcomes, and potential cost savings 
        associated with remote monitoring for individuals who are 
        prescribed opioids compared to such individuals who are not so 
        monitored;
            (2) an assessment of the current prevalence of remote 
        monitoring for individuals who are prescribed opioids, 
        including the use of such monitoring for such individuals in 
        other countries; and
            (3) recommendations to improve availability, access, and 
        coverage for remote monitoring for individuals who are 
        prescribed opioids, including through changes to Federal health 
        care programs (as defined in section 1128B of the Social 
        Security Act (42 U.S.C. 1320a-7b)) and, if determined 
        appropriate by the Comptroller General, an identification of 
        cohorts of individuals who stand to benefit the most from 
        remote monitoring when prescribed opioids.
                                 <all>